DD145062A5 - Transparentes fluessigkeitsverbandsmaterial - Google Patents
Transparentes fluessigkeitsverbandsmaterial Download PDFInfo
- Publication number
- DD145062A5 DD145062A5 DD79214548A DD21454879A DD145062A5 DD 145062 A5 DD145062 A5 DD 145062A5 DD 79214548 A DD79214548 A DD 79214548A DD 21454879 A DD21454879 A DD 21454879A DD 145062 A5 DD145062 A5 DD 145062A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- gel
- item
- dried
- dressing material
- material according
- Prior art date
Links
- 239000000463 material Substances 0.000 title claims description 56
- 239000007788 liquid Substances 0.000 title claims description 17
- 239000000499 gel Substances 0.000 claims description 35
- 206010052428 Wound Diseases 0.000 claims description 27
- 208000027418 Wounds and injury Diseases 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 9
- 229920001282 polysaccharide Polymers 0.000 claims description 9
- 239000005017 polysaccharide Substances 0.000 claims description 9
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 8
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 239000012779 reinforcing material Substances 0.000 claims description 8
- 229920000936 Agarose Polymers 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 7
- 238000006116 polymerization reaction Methods 0.000 claims description 7
- 239000007858 starting material Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 235000015097 nutrients Nutrition 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000003630 growth substance Substances 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 239000003999 initiator Substances 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000002131 composite material Substances 0.000 claims 1
- 238000001879 gelation Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000035876 healing Effects 0.000 description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 7
- 239000012153 distilled water Substances 0.000 description 7
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 4
- -1 polytetrafluoroethylene Polymers 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000206672 Gelidium Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000002260 Keloid Diseases 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 206010029098 Neoplasm skin Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 210000001117 keloid Anatomy 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 2
- 238000006068 polycondensation reaction Methods 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- KHOUKKVJOPQVJM-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;prop-2-enoic acid Chemical class OC(=O)C=C.OCC(CO)(CO)CO KHOUKKVJOPQVJM-UHFFFAOYSA-N 0.000 description 1
- GNMGAVKSZFQCDD-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate;3-hydroxypropyl prop-2-enoate Chemical compound OCCOC(=O)C=C.OCCCOC(=O)C=C GNMGAVKSZFQCDD-UHFFFAOYSA-N 0.000 description 1
- MTPJEFOSTIKRSS-UHFFFAOYSA-N 3-(dimethylamino)propanenitrile Chemical compound CN(C)CCC#N MTPJEFOSTIKRSS-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 206010048625 Skin maceration Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000019395 ammonium persulphate Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- GHJOIQFPDMIKHT-UHFFFAOYSA-N propane-1,2,3-triol;prop-2-enoic acid Chemical class OC(=O)C=C.OCC(O)CO GHJOIQFPDMIKHT-UHFFFAOYSA-N 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 description 1
- 229960004267 taurolidine Drugs 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000011240 wet gel Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Connector Housings Or Holding Contact Members (AREA)
- Pens And Brushes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19782849570 DE2849570A1 (de) | 1977-06-03 | 1978-11-15 | Transparentes fluessigkeitsverbandsmaterial |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD145062A5 true DD145062A5 (de) | 1980-11-19 |
Family
ID=6054751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD79214548A DD145062A5 (de) | 1978-11-15 | 1979-07-23 | Transparentes fluessigkeitsverbandsmaterial |
Country Status (22)
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0168917A1 (en) * | 1984-05-07 | 1986-01-22 | Lloyd A. Ferreira | Conductive material and biomedical electrode |
| DE202008009795U1 (de) | 2008-07-22 | 2008-09-25 | Neubauer, Norbert | Wundauflage |
| DE202009013208U1 (de) | 2009-10-01 | 2010-02-18 | Neubauer, Norbert | Vakuumventil |
| DE202009016141U1 (de) | 2009-11-26 | 2010-03-04 | Neubauer, Norbert | Vakuumventil |
| DE202015007868U1 (de) | 2015-11-14 | 2016-01-26 | Norbert Neubauer | Belüftungsdrain für Wunden |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE448203B (sv) * | 1980-09-10 | 1987-02-02 | Johan Alfred Olof Johansson | formkropp framstelld av agar och/eller agaros och/eller ett derivat derav innehallande farmakologiskt verksamt emne |
| SE446688C (sv) * | 1982-09-14 | 1989-10-16 | Magnus Hoeoek | Medel foer avlaegsnande av mikroorganismer fraan vaevnader, vilket bestaar av ett protein som kan bindas till mikroorganismerna |
| JPS6045522B2 (ja) * | 1982-12-08 | 1985-10-09 | 憲司 中村 | 化粧用具 |
| EP0137743A3 (en) * | 1983-09-13 | 1986-10-01 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
| GB8415188D0 (en) * | 1984-06-14 | 1984-07-18 | Geistlich Soehne Ag | Absorbent polymer material |
| GB8418772D0 (en) * | 1984-07-24 | 1984-08-30 | Geistlich Soehne Ag | Chemical substances |
| EP0345370A1 (en) * | 1988-06-08 | 1989-12-13 | Malliner Laboratories Inc. | Use of transparent membranes made of hydrogel polymers as a cover for various organs during surgery |
| US4587284A (en) * | 1985-06-14 | 1986-05-06 | Ed. Geistlich Sohne Ag Fur Chemische Industrie | Absorbent polymer material and its preparation |
| GB8705985D0 (en) * | 1987-03-13 | 1987-04-15 | Geistlich Soehne Ag | Dressings |
| DE3827561C1 (enrdf_load_stackoverflow) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| GB2229443A (en) * | 1989-03-07 | 1990-09-26 | American Cyanamid Co | Wound dressings |
| US5196190A (en) * | 1990-10-03 | 1993-03-23 | Zenith Technology Corporation, Limited | Synthetic skin substitutes |
| IL132880A0 (en) * | 1999-11-11 | 2001-03-19 | Hanita Lenses | Hydrogel sheets |
| FR2817479A1 (fr) * | 2000-12-01 | 2002-06-07 | Philippe Maingault | Composition d'activation cellulaire, son procede de fabrication et son utilisation pour le traitement de lesions |
| EP1455849B1 (en) | 2001-12-21 | 2005-11-23 | Coloplast A/S | A wound care device |
| US20030220632A1 (en) * | 2002-05-23 | 2003-11-27 | Wolfgang Strasser | Method of using gel sheets for laser treatment |
| WO2007114726A1 (fr) | 2006-04-06 | 2007-10-11 | Boris Karpovich Gavrilyuk | Revêtement monocouche pour plaies et blessures et procédé de fabrication correspondant |
| CN109157673A (zh) * | 2018-10-25 | 2019-01-08 | 闫玮钰 | 一种液体创可贴 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE876311C (de) * | 1950-11-15 | 1953-05-11 | Bayer Ag | Verfahren zur Herstellung von selbsthaertenden Verbandsmaterialien |
| US3670731A (en) * | 1966-05-20 | 1972-06-20 | Johnson & Johnson | Absorbent product containing a hydrocolloidal composition |
| FR1596790A (enrdf_load_stackoverflow) * | 1968-11-27 | 1970-06-22 | ||
| ZA711727B (en) * | 1970-03-24 | 1971-12-29 | Itek Corp | Gelled burn-treating solutions |
| SE452109B (sv) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | Rengoringsmedel for vetskande utvertes sarytor |
| CH616694A5 (en) * | 1974-06-27 | 1980-04-15 | Ciba Geigy Ag | Process for the preparation of crosslinked, water-insoluble, hydrophilic copolymers |
| FR2297879A1 (fr) * | 1975-01-14 | 1976-08-13 | Sogeras | Procede de preparation de plaques sechees rehydratables contenant de l'agarose ou de la gelose |
-
1979
- 1979-06-25 AT AT0444779A patent/AT371723B/de not_active IP Right Cessation
- 1979-06-26 NO NO792135A patent/NO147439C/no unknown
- 1979-06-27 FI FI792030A patent/FI70140C/fi not_active IP Right Cessation
- 1979-06-28 AR AR277098A patent/AR223976A1/es active
- 1979-06-29 SE SE7905729A patent/SE443925B/sv not_active IP Right Cessation
- 1979-07-02 DK DK278579A patent/DK152091C/da active
- 1979-07-09 NL NL7905340A patent/NL7905340A/nl not_active Application Discontinuation
- 1979-07-09 BE BE0/196202A patent/BE877580A/xx not_active IP Right Cessation
- 1979-07-18 HU HU79MA3181A patent/HU180013B/hu unknown
- 1979-07-20 IT IT24517/79A patent/IT1122228B/it active
- 1979-07-22 IL IL57918A patent/IL57918A/xx unknown
- 1979-07-23 DD DD79214548A patent/DD145062A5/de unknown
- 1979-07-24 AU AU49197/79A patent/AU525408B2/en not_active Ceased
- 1979-07-25 ZA ZA00793805A patent/ZA793805B/xx unknown
- 1979-08-21 ES ES483519A patent/ES483519A1/es not_active Expired
- 1979-09-10 PL PL1979218227A patent/PL118053B1/pl unknown
- 1979-11-05 GB GB7938266A patent/GB2036042B/en not_active Expired
- 1979-11-13 CA CA000339735A patent/CA1116517A/en not_active Expired
- 1979-11-14 CS CS797797A patent/CS221904B2/cs unknown
- 1979-11-14 CH CH1017479A patent/CH655662B/de unknown
- 1979-11-15 JP JP14716279A patent/JPS5568369A/ja active Granted
- 1979-11-15 FR FR7928251A patent/FR2441390A2/fr active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0168917A1 (en) * | 1984-05-07 | 1986-01-22 | Lloyd A. Ferreira | Conductive material and biomedical electrode |
| DE202008009795U1 (de) | 2008-07-22 | 2008-09-25 | Neubauer, Norbert | Wundauflage |
| DE202009013208U1 (de) | 2009-10-01 | 2010-02-18 | Neubauer, Norbert | Vakuumventil |
| DE202009016141U1 (de) | 2009-11-26 | 2010-03-04 | Neubauer, Norbert | Vakuumventil |
| DE202015007868U1 (de) | 2015-11-14 | 2016-01-26 | Norbert Neubauer | Belüftungsdrain für Wunden |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD145062A5 (de) | Transparentes fluessigkeitsverbandsmaterial | |
| CH637833A5 (de) | Transparentes fluessigkeitsverbandmaterial, seine herstellung und verwendung. | |
| EP0048323B1 (de) | Wundbehandlungsmittel in Pulverform und Verfahren zu seiner Herstellung | |
| DE2725261C2 (de) | Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung | |
| DE69830166T2 (de) | Neue arzneimittel auf der basis von polymeren aus mit methacrylamid modifizierter gelatine | |
| DE69817574T2 (de) | Herstellungsmethode für ein faserfreies, poröses material | |
| AT393795B (de) | Kohaerentes, poroeses kollagenfolienmaterial und verfahren zu seiner herstellung | |
| DE69829690T2 (de) | Verbesserte wundauflagen | |
| DE69228162T2 (de) | Netzverband und Verfahren zu seiner Herstellung | |
| DE1617393C2 (de) | Verfahren zur Herstellung von biologisch aktive Stoffe enthaltenden hydrophilen vernetzten Copolymeren | |
| EP1084716B1 (de) | Wundauflage zur gesteuerten Abgabe von Wirkstoff an Wunden und Verfahren zu ihrer Herstellung | |
| DE69013416T2 (de) | Wundverband und Verfahren zu seiner Herstellung. | |
| DE69214732T2 (de) | Heilender Wundverband | |
| DE3744289C2 (enrdf_load_stackoverflow) | ||
| DE69918707T2 (de) | Wundverband aus hydrogelmit quaternären aminen der von sich aus mikrobentötend ist | |
| EP2322232B1 (de) | Verfahren zur herstellung einer schichtförmigen wundauflage | |
| DE3128815A1 (de) | Polymeres verbundmaterial, seine herstellung und verwendung | |
| DE2933250A1 (de) | Abdeckmaterial | |
| DE1617780B2 (de) | Vernarbungsmittel | |
| DE69010317T2 (de) | Acrylgel und seine Herstellung. | |
| DE19712699C2 (de) | Verfahren zur Herstellung von Wundschnellverbänden mit wundversorgungsaktiven Stoffen | |
| DE3204512A1 (de) | Polypeptid-haltiges folienmaterial fuer kosmetische und pharmazeutische zwecke | |
| DE202023100113U1 (de) | Dreidimensional vernetztes Hydrogel | |
| DE3912693C2 (enrdf_load_stackoverflow) | ||
| EP4134107A1 (de) | Wundauflage mit einer hydrogelschicht und einer wundkontaktschicht umfassend hyaluronsäure |